Allergic Bronchopulmonary Aspergillosis (ABPA)

Allergic Bronchopulmonary Aspergillosis (ABPA)

ABPA is an allergic reaction in the lungs caused by the fungus Aspergillus, which colonizes the airways especially in patients with asthma or cystic fibrosis. In this the immune system reacts excessively to Aspergillus spores. It causes inflammation and damage to the airways. Leads to recurrent asthma exacerbations, mucus plugging, and sometimes bronchiectasis.

Symptoms of ABPA

Causes of ABPA

It can cause due to:

Diagnosis

ABPA can be diagnosed by:

Treatment for ABPA

  1. Oral Corticosteroids (First-line Treatment): Prednisolone is the mainstay, usually started in moderate-to-high doses and then tapered over weeks/months. Helps to reduce the lung inflammation and control the symptoms.
  2. Antifungal Therapy: Itraconazole or Voriconazole is added in some cases to reduce fungal load. It helps to decrease the steroid dependence and prevents flare-ups.
  3. Inhaled Bronchodilators & Steroids: It is useful if patient has underlying asthma. It helps to control the airway hyperreactivity
  4. Monitoring & Follow-up: Regular check of IgE levels to monitor the disease’s activity. Repeat the HRCT scan if symptoms get worse. Watch for side effects of long-term steroid use

Frequently Asked Questions (FAQs)

It is rare but occurs in some people who have asthma or cystic fibrosis.

ABPA is a complication in which the fungal allergy worsens asthma symptoms and causes lung damage.

Not completely, but its symptoms and lung damage can be controlled with treatment.

Yes, if it remains untreated it can cause bronchiectasis and fibrosis.

Make An Appointment